Cabozantinib and Dostarlimab in Recurrent Gynecologic Carcinosarcoma
University of Alabama at Birmingham
University of Alabama at Birmingham
Institut du Cancer de Montpellier - Val d'Aurelle
Imperial College London
Northwestern University
Northwestern University
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Centre Oscar Lambret
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Duke University
Dana-Farber Cancer Institute
University of Miami
University of Tennessee Graduate School of Medicine
Asan Medical Center
Dana-Farber Cancer Institute
University of Alabama at Birmingham
Rutgers, The State University of New Jersey
University of Kentucky
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Yuri Semenyuk Rivne Regional Clinical Hospital
Washington University School of Medicine
City of Hope Medical Center
University Health Network, Toronto
Assiut University
Icahn School of Medicine at Mount Sinai
University Health Network, Toronto
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
Stanford University
University of Virginia
M.D. Anderson Cancer Center
University of California, San Diego
Washington University School of Medicine
Emory University
Washington University School of Medicine
Northwell Health
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Jonsson Comprehensive Cancer Center
University of Alabama at Birmingham
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Abramson Cancer Center at Penn Medicine
M.D. Anderson Cancer Center
Northwestern University
Arbeitsgemeinschaft medikamentoese Tumortherapie
New York Stem Cell Foundation Research Institute
UNC Lineberger Comprehensive Cancer Center
Indiana University
University Hospital Tuebingen